LAPTM4B
LAPTM4B (lysosomal protein transmembrane 4 beta, also known as LC27) is a multi-compartment membrane protein of the endolysosomal system. It is required for optimal lysosomal function and links lipid binding to the control of receptor degradation, amino acid entry and mTORC1 activation. Browse Assay Genie's current range of LAPTM4B research reagents below, or read on for the biology behind the target.
LAPTM4B is required for optimal lysosomal function, and it acts at several points in endosomal and lysosomal signalling. It blocks EGF-stimulated intraluminal sorting and degradation of EGFR. By binding phosphatidylinositol 4,5-bisphosphate, it regulates the interaction with PIP5K1C, inhibits ubiquitination of HGS and so relieves its own inhibition of EGFR degradation. NCBI Gene annotation likewise lists roles in endosome transport via the multivesicular body sorting pathway and negative regulation of lysosomal protein catabolism.
The protein also supports nutrient sensing. It recruits SLC3A2 and SLC7A5, the leucine transporter, to the lysosome, which promotes entry of leucine and other essential amino acids. This stimulates the proton-transporting vacuolar (V)-ATPase and, in turn, activation of mTORC1. In regulatory T cells, LAPTM4B acts as a negative regulator of TGFB1 production. It binds ceramide and facilitates its exit from the late endosome, which helps control cell death pathways. Annotated binding activities include ceramide, phosphatidylinositol bisphosphate and enzymes.
LAPTM4B belongs to the lysosomal protein transmembrane family and the LAPTM4/LAPTM5 transporter family. It is found in the endomembrane system, including late endosome, multivesicular body and lysosome membranes, as well as the cell membrane and cell projections. Mouse and rat both carry a Laptm4b ortholog. Researchers studying the LAPTM4B gene or protein often work on lysosomal signalling, receptor trafficking and lipid-regulated pathways.
LAPTM4B is required for optimal lysosomal function and is located in the lysosomal membrane, making it a useful subject for studying lysosome regulation.
LAPTM4B blocks EGF-stimulated EGFR intraluminal sorting and degradation, and its lipid-dependent regulation of PIP5K1C and HGS is relevant to receptor fate.
By recruiting SLC3A2 and SLC7A5 to the lysosome, LAPTM4B promotes essential amino acid entry, V-ATPase stimulation and mTORC1 activation.
LAPTM4B binds ceramide and facilitates its exit from late endosomes, linking endosomal lipid handling to the control of cell death pathways.
LAPTM4B is required for optimal lysosomal function. It blocks EGF-stimulated EGFR sorting and degradation, recruits SLC3A2 and SLC7A5 to the lysosome to promote amino acid entry and mTORC1 activation, and binds ceramide to facilitate its exit from late endosomes.
The HGNC name is lysosomal protein transmembrane 4 beta, and UniProt lists the protein as lysosomal-associated transmembrane protein 4B. LC27 is a recorded alias. Check the datasheet of any product for its validated reactivity and the exact protein region targeted.
LAPTM4B belongs to the LAPTM4/LAPTM5 transporter family and the HGNC lysosomal protein transmembrane family. Orthologs are annotated in mouse and rat, both named Laptm4b, so rodent models can be used to study it.
Receptors, amino acid transporters and signalling proteins that work alongside LAPTM4B in endolysosomal regulation.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q86VI4; product specifications from Assay Genie datasheets.